Compared to the AKI group, the apoptosis markers (Bax and active-caspase 3) were visibly reduced in the pEV and cEV treatment groups, and the effect was more significant in the former (Figure 3H, I, L-M). This evidence concerns the gene CASP3 and acute kidney injury.